The animal model market is expected to grow at a CAGR of 8.5% during the forecast period of 2025 to 2033. The identified drivers, including the increasing utilization in cancer research, rising significance in immunological disease studies, and key contributions to infectious disease research, emphasize the pivotal role of animal models in advancing scientific knowledge. The restraint related to ethical and regulatory challenges underscores the industry's responsibility to address ethical considerations and navigate evolving regulatory frameworks.
The cell cryopreservation market plays a vital role in preserving and safeguarding various cell types for applications in research, regenerative medicine, and assisted reproductive technology. The cell cryopreservation market plays a pivotal role in regenerative medicine, assisted reproductive technology, and biobanking. The cell cryopreservation market is expected to grow at a CAGR of 21.5% during the forecast period of 2025 to 2033. While technological challenges exist, the market continues to grow due to the expansion of regenerative medicine, ART, and research activities.
The preparative and process chromatography market is expected to grow at a CAGR of 8.1% during the forecast period of 2025 to 2033. The market has been undergoing significant transformation in recent years, driven by several key factors. The preparative and process chromatography market is poised for robust growth, driven by factors such as pharmaceutical advancements, environmental concerns, and the expansion of biotechnology. As the demand for biopharmaceuticals and high-value chemicals continues to surge, the chromatography market will play a pivotal role in ensuring product quality and purity.
miRNA, or microRNA, are small non-coding RNAs that play a vital role in the regulation of gene expression. The miRNA Sequencing and Assay market revolves around the technologies and methodologies employed to study these RNA molecules, which have been linked to various disease mechanisms and are often the subject of innovative therapeutic research. miRNA sequencing and assay market is estimated to grow at a CAGR of 13.1% from 2025 to 2033, driven by increasing significance in cancer research and technological advancements in RNA sequencing.
The chemoinformatics market is expected to grow at a CAGR of 15.6% during the forecast period of 2025 to 2033. It is a crucial component of the pharmaceutical and chemical industries, is poised for substantial growth from 2025 to 2033. This expansion is driven by several key factors, including advancements in chemical analysis, drug discovery, and molecular modeling. The market plays a pivotal role in streamlining research processes, reducing costs, and accelerating the development of new compounds.
The recombinant proteins manufacturing services market is expected to grow at a CAGR of 18% during the forecast period of 2025 to 2033, recombinant proteins manufacturing services market plays a pivotal role in the biotechnology sector, providing essential support for research, diagnostics, and therapeutic developments. The recombinant proteins manufacturing services market occupies a central position within the biotechnology domain, supporting the development of groundbreaking therapies and facilitating academic research globally.
The liquid-handling technology market is expected to grow at a CAGR of 8.5% during the forecast period of 2025 to 2033, liquid-handling technology market plays a pivotal role in various scientific and medical domains by providing precise and automated solutions for the accurate handling of liquids. the Liquid Handling Technology market plays a vital role in advancing scientific research and pharmaceutical development. The drivers, including drug discovery, cancer genomics, and bioprocessing, continue to propel the market forward. However, the high initial costs and technical expertise required represent significant challenges.
The global industrial microbiology testing services market is expected to grow at a CAGR of 9.5% during the forecast period of 2025 to 2033. The Industrial Microbiology Testing Services market plays a pivotal role in ensuring the safety and quality of products across various industries. The Industrial Microbiology Testing Services market is integral to ensuring the safety, quality, and compliance of products across diverse industries. Stringent regulations, heightened consumer awareness, and technological advancements continue to drive market growth.
The image-based cytometry in cell analysis market is expected to grow at a CAGR of 10.50% during the forecast period of 2025 to 2033, image-based cytometry in cell analysis market is a dynamic sector that plays a pivotal role in advancing cell analysis and research through innovative imaging technologies. The Image-Based Cytometry in Cell Analysis Market is driven by technological advancements, personalized medicine trends, and the integration of AI and ML technologies. However, the complexity of data interpretation presents a challenge to harnessing the full potential of image-based cytometry.
The cell and gene therapy manufacturing market is expected to grow at a CAGR of 17.3% during the forecast period of 2025 to 2033. The market has emerged as a groundbreaking sector within the biopharmaceutical industry, revolutionizing medical treatment through personalized therapies. The cell and gene therapy manufacturing market is driven by advancements in cellular engineering, rising disease prevalence, and a supportive regulatory environment. Complex manufacturing processes pose challenges that need to be addressed to ensure consistent product quality and reproducibility.
The global biotechnology market is anticipated to expand at a CAGR of 15% between 2023 and 2030. Government measures aiming at the modernization of the regulatory environment, improvements in approval processes and reimbursement policies, and standardization of clinical research are driving the market. The expanding influence of personalized medicine and the growing number of orphan drug formulations are creating new opportunities for biotechnology applications, encouraging the emergence of creative biotechnology firms, and enhancing market revenue.
Furthermore, genetically engineered crops and herbicide-tolerant and insect-resistant seeds are gaining popularity and contributing to market expansion. Increasing adoption of tissue culture technology for the production of novel rice variants and disease- and pest-free banana varieties in South Asia and Africa, as well as the use of the technology for the cloning of disease-free and nutrient-rich plant varieties, have propelled agricultural applications for biotechnology. A robust clinical trial pipeline and substantial funding opportunities in tissue engineering and regeneration technologies also drive the industry.
Nanobiotechnology is anticipated to grow at the highest CAGR of 14.8% between 2022 and 2030, due to an increase in nanomedicine approvals and the introduction of advanced technology. For instance, applications of theranostics nanoparticles have gained momentum in order to facilitate quick diagnosis and individualization of therapy choices for several diseases simultaneously. Nanoparticles' low toxicity, smaller size, and chemical adaptability have proven advantageous in overcoming the limitations associated with conventional generic drug administration routes. In addition, tissue engineering and regeneration medicine had a sizable proportion of the market due to government and private expenditures in the field, high healthcare spending, and the existence of numerous mature and emerging competitors in this market.
Acute Market Reports is a market research and strategic consulting company specializing in the biotechnology and healthcare industry. The futuristic research technique offered by Acute Market Reports enables our clients to make timely, well-considered business decisions. We partner with a wide range of industry participants to provide cutting-edge strategic research solutions to our global clients.
